Skip to content
Medical Health Aged Care

Australian Society of Anaesthetists responds to Private Health Australia’s claims on out-of-pocket costs

Australian Society of Anaesthetists (ASA) 2 mins read

While there is no dispute that many Australians face growing healthcare cost pressures, the ASA believes that a meaningful discussion must also take into account the increase in private health insurance (PHI) premiums and the lack of indexation with Medicare benefit rates.

“While we recognise the very real pressure on patients, the notion that specialist out-of-pocket cost increases can be viewed in isolation is misleading,” says ASA President Vida Viliunas.

“The broader system context—including rising insurance premiums and insurer profitability—must be part of the conversation. If the PHI industry is charging households more yet paying out relatively less, then we risk having patients caught in the middle: meeting higher premiums, facing higher gaps, and specialists absorbing pressures too,” Dr Viliunas stated.

The ASA calls on all stakeholders—including consumers, insurers, medical specialists, hospitals and government—to engage in a comprehensive review of:

  1. The level and nature of out-of-pocket costs for specialist care (including anaesthesia) in the private sector.
  2. The growth in PHI premiums and how they compare with benefit payouts, gap sizes and indexing arrangements.
  3. Transparency in cost drivers: what proportion of premium increases is attributable to insurer administration and profitability, versus clinical/technology cost escalation.
  4. Policy reforms which ensure that patients are not disproportionately burdened by dual cost increases—both via premiums and out-of-pocket bills.

“The private specialist sector is a proud contributor to high quality patient care, but with the dual pressures of insurance-cost escalation and gap growth, something needs to give. We urge the PHI industry and the government to work with us to deliver a sustainable, transparent system that treats patients fairly, supports specialists and keeps the total cost curve in check.  Afterall, the more we prevaricate on these issues the focus on the provision of high quality patient focussed care and good outcomes is clouded,”  Dr Viliunas concluded.


About us:

About the Australian Society of Anaesthetists
The ASA represents anaesthetists working across Australia in private, public and mixed practice settings. Our mission is to promote and support high-quality anaesthesia care, advocate for safe working conditions and fair remuneration, and ensure that patient access to specialist anaesthesia is preserved and enhanced.


Contact details:

Leon Beswick / 0414 332267

Media

More from this category

  • Medical Health Aged Care
  • 21/01/2026
  • 06:10
Amoeba

Gold medal winner at SIVAL, Amoéba displays its ambitions for its biocontrol solution

Chassieu, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Chassieu (France), 20 January 2026 – 6:00 pm -Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of amoebae, recaps its recent participation in SIVAL (International Exhibition of Plant Production Techniques) in Angers (France). During this leading European and global event for the crop industry, Amoéba won the gold medal in the SIVAL Innovation 2026 Competition for its biocontrol solution and announced, together with its partner Koppert, the commercial launch in 2026 of its biocontrol solution for treating vineyards and vegetable crops as…

  • Medical Health Aged Care
  • 21/01/2026
  • 00:41
Crown Bioscience

Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities

SAN DIEGO–BUSINESS WIRE– Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory…

  • Contains:
  • Medical Health Aged Care
  • 20/01/2026
  • 10:00
Monash University

Monash University researcher appointed to the board of the Asthma Council

The National Asthma Council Australia (NAC) has announced the appointment of Pharmaceutical Society of Australia (PSA) nominee Dr Amanda Cross to the board. Dr Cross is a clinical pharmacist and Senior Research Fellow at Monash University's Centre for Medicine Use and Safety, within the Monash Institute of Pharmaceutical Sciences (MIPS). Her work focuses on medicine safety and quality use of medicines for older adults. She is particularly interested in the role of healthcare professionals working as knowledge brokers to support the uptake of research evidence and guidelines into clinical practice. Evidence-to-practice gaps are a major barrier to avoiding medication-related harm.…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.